Learn more

XOMA CORP

Overview
  • Total Patents
    452
  • GoodIP Patent Rank
    235,353
About

XOMA CORP has a total of 452 patent applications. Its first patent ever was published in 1982. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are KIRIN AMGEN, MEDIMMUNE INC and JENSENIUS JENS CHRISTIAN.

Patent filings per year

Chart showing XOMA CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Scannon Patrick J 73
#2 Little Roger G Ii 52
#3 Better Marc D 43
#4 Horwitz Arnold 39
#5 Theofan Georgia 34
#6 Carroll Stephen F 33
#7 Robinson Randy R 31
#8 Carroll Stephen Fitzhugh 27
#9 Lambert Lewis H Jr 26
#10 Horwitz Arnold H 26

Latest patents

Publication Filing date Title
FI20050243A DNA encoding a stable bactericidal / permeability-increasing protein fragment, vector, host cell and method for producing these protein fragments
US2004023884A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6686332B1 Method of treating depressed reticuloendothelial system function
US6271203B1 Anti-protozoan methods and materials
US6482796B2 Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6759203B1 Method for quantifying BPI in body fluids
US6146850A Proteins encoding gelonin sequences
AU8472298A Bactericidal/permeability-increasing protein: crystallization, X-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteins
US6013631A Bactericidal/permeability-increasing protein (BPI) deletion analogs
NZ329583A Use of a BPI protein and an antibiotic to treat bacterial infections
NZ335401A Therapeutic uses of BPI protein products in cystic fibrosis patients
US5990082A Uses of lipopolysaccharide binding protein
US6274348B1 Methods for the preparation of positively charged proteins
NZ332954A Use of BPI protein products to treat humans with hemorrhage due to trauma
CN1222858A Antithrombotic materials and methods
CA2253837A1 Therapeutic uses of bpi protein products for human meningococcemia
US5891618A Method for quantifying LBP in body fluids
WO9717990A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury
US5888973A Anti-chlamydial uses of BPI protein products
US5741779A Antithrombotic materials and methods